# Modine Manufacturing Co: financial statements, quarterly

MOD · NYSE · CIK 67347 · [Consumer discretionary](/sectors/consumer-discretionary.md) · fiscal year ends Mar 31

Pages: [Overview](/companies/mod.md) · [Financials](/companies/mod/financials.md) · [Filings](/companies/mod/filings.md) · [Insiders](/companies/mod/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/mod/financials.md?period=annual).

## Income statement

| Line item | Unit | Q2 FY2024 (2023-09-30) | Q3 FY2024 (2023-12-31) | Q4 FY2024 (2024-03-31) | Q1 FY2025 (2024-06-30) | Q2 FY2025 (2024-09-30) | Q3 FY2025 (2024-12-31) | Q4 FY2025 (2025-03-31) | Q1 FY2026 (2025-06-30) | Q2 FY2026 (2025-09-30) | Q3 FY2026 (2025-12-31) | Q4 FY2026 (2026-03-31) | Q1 FY2027 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [621](/filings/0001558370-24-013912.md) | [561](/filings/0001558370-25-000648.md) | [604 d](/filings/0001104659-26-066795.md) | [662](/filings/0001558370-25-009865.md) | [658](/filings/0001104659-25-103646.md) | [617](/filings/0001104659-26-010790.md) | [647 d](/filings/0001104659-26-066795.md) | [683](/filings/0001104659-26-088569.md) | [739](/filings/0001104659-25-103646.md) | [805](/filings/0001104659-26-010790.md) | [954 d](/filings/0001104659-26-066795.md) | [874](/filings/0001104659-26-088569.md) |
| Cost of revenue | $m | [485](/filings/0001558370-24-013912.md) | [434](/filings/0001558370-25-000648.md) | [468 d](/filings/0001104659-26-066795.md) | [499](/filings/0001558370-25-009865.md) | [492](/filings/0001104659-25-103646.md) | [467](/filings/0001104659-26-010790.md) | [481 d](/filings/0001104659-26-066795.md) | [517](/filings/0001104659-26-088569.md) | [574](/filings/0001104659-25-103646.md) | [619](/filings/0001104659-26-010790.md) | [740 d](/filings/0001104659-26-066795.md) | [692](/filings/0001104659-26-088569.md) |
| Gross profit | $m | [135](/filings/0001558370-24-013912.md) | [127](/filings/0001558370-25-000648.md) | [135 d](/filings/0001104659-26-066795.md) | [163](/filings/0001558370-25-009865.md) | [166](/filings/0001104659-25-103646.md) | [150](/filings/0001104659-26-010790.md) | [166 d](/filings/0001104659-26-066795.md) | [165](/filings/0001104659-26-088569.md) | [165](/filings/0001104659-25-103646.md) | [186](/filings/0001104659-26-010790.md) | [215 d](/filings/0001104659-26-066795.md) | [182](/filings/0001104659-26-088569.md) |
| Selling, general and administrative | $m | [68.9](/filings/0001558370-24-013912.md) | [68.0](/filings/0001558370-25-000648.md) | [75.6 d](/filings/0001104659-26-066795.md) | [82.8](/filings/0001558370-25-009865.md) | [85.8](/filings/0001104659-25-103646.md) | [82.0](/filings/0001104659-26-010790.md) | [81.5 d](/filings/0001104659-26-066795.md) | [84.9](/filings/0001104659-26-088569.md) | [84.2](/filings/0001104659-25-103646.md) | [89.3](/filings/0001104659-26-010790.md) | [102 d](/filings/0001104659-26-066795.md) | [103](/filings/0001104659-26-088569.md) |
| Operating income | $m | [65.7](/filings/0001558370-24-013912.md) | [61.7](/filings/0001558370-25-000648.md) | [46.8 d](/filings/0001104659-26-066795.md) | [74.4](/filings/0001558370-25-009865.md) | [75.3](/filings/0001104659-25-103646.md) | [59.3](/filings/0001104659-26-010790.md) | [74.5 d](/filings/0001104659-26-066795.md) | [75.7](/filings/0001104659-26-088569.md) | [73.5](/filings/0001104659-25-103646.md) | [89.3](/filings/0001104659-26-010790.md) | [104 d](/filings/0001104659-26-066795.md) | [74.8](/filings/0001104659-26-088569.md) |
| Interest expense | $m | [6.1](/filings/0001140361-23-051058.md) | [5.8](/filings/0001140361-24-004740.md) | [6.3 d](/filings/0001558370-25-008058.md) | [7.5](/filings/0001558370-25-009865.md) | [7.4](/filings/0001104659-25-103646.md) | [6.2](/filings/0001104659-26-010790.md) | [5.3 d](/filings/0001558370-25-008058.md) | [5.8](/filings/0001104659-26-088569.md) | [8.3](/filings/0001104659-25-103646.md) | [8.9](/filings/0001104659-26-010790.md) | [8.6 d](/filings/0001104659-26-066795.md) | [6.4](/filings/0001104659-26-088569.md) |
| Income tax | $m | [12.8](/filings/0001558370-24-013912.md) | [10.3](/filings/0001558370-25-000648.md) | [13.4 d](/filings/0001104659-26-066795.md) | [18.8](/filings/0001558370-25-009865.md) | [20.0](/filings/0001104659-25-103646.md) | [13.0](/filings/0001104659-26-010790.md) | [16.7 d](/filings/0001104659-26-066795.md) | [14.0](/filings/0001104659-26-088569.md) | [18.9](/filings/0001104659-25-103646.md) | [8.3](/filings/0001104659-26-010790.md) | [22.0 d](/filings/0001104659-26-066795.md) | [(5.7)](/filings/0001104659-26-088569.md) |
| Net income | $m | [46.5](/filings/0001558370-24-013912.md) | [44.4](/filings/0001558370-25-000648.md) | [25.8 d](/filings/0001104659-26-066795.md) | [47.3](/filings/0001558370-25-009865.md) | [46.1](/filings/0001104659-25-103646.md) | [41.0](/filings/0001104659-26-010790.md) | [49.6 d](/filings/0001104659-26-066795.md) | [51.2](/filings/0001104659-26-088569.md) | [44.4](/filings/0001104659-25-103646.md) | [(47.4)](/filings/0001104659-26-010790.md) | [73.3 d](/filings/0001104659-26-066795.md) | [73.9](/filings/0001104659-26-088569.md) |
| Diluted EPS | $ per share | [0.87](/filings/0001558370-24-013912.md) | [0.83](/filings/0001558370-25-000648.md) | not reported | [0.88](/filings/0001558370-25-009865.md) | [0.86](/filings/0001104659-25-103646.md) | [0.76](/filings/0001104659-26-010790.md) | not reported | [0.95](/filings/0001104659-26-088569.md) | [0.83](/filings/0001104659-25-103646.md) | [(0.90)](/filings/0001104659-26-010790.md) | not reported | [1.37](/filings/0001104659-26-088569.md) |
| Basic EPS | $ per share | [0.89](/filings/0001558370-24-013912.md) | [0.85](/filings/0001558370-25-000648.md) | not reported | [0.90](/filings/0001558370-25-009865.md) | [0.88](/filings/0001104659-25-103646.md) | [0.78](/filings/0001104659-26-010790.md) | not reported | [0.97](/filings/0001104659-26-088569.md) | [0.84](/filings/0001104659-25-103646.md) | [(0.90)](/filings/0001104659-26-010790.md) | not reported | [1.39](/filings/0001104659-26-088569.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: us-gaap:CostOfGoodsAndServicesSold
- Gross profit: us-gaap:GrossProfit
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense, us-gaap:InterestExpenseNonoperating
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q2 FY2024 (2023-09-30) | Q3 FY2024 (2023-12-31) | FY2024 (2024-03-31) | Q1 FY2025 (2024-06-30) | Q2 FY2025 (2024-09-30) | Q3 FY2025 (2024-12-31) | FY2025 (2025-03-31) | Q1 FY2026 (2025-06-30) | Q2 FY2026 (2025-09-30) | Q3 FY2026 (2025-12-31) | FY2026 (2026-03-31) | Q1 FY2027 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [120](/filings/0001140361-23-051058.md) | [150](/filings/0001140361-24-004740.md) | [60.1](/filings/0001558370-25-008058.md) | [72.9](/filings/0001140361-24-035058.md) | [78.6](/filings/0001558370-24-013912.md) | [83.8](/filings/0001558370-25-000648.md) | [71.6](/filings/0001104659-26-066795.md) | [125](/filings/0001558370-25-009865.md) | [83.8](/filings/0001104659-25-103646.md) | [98.7](/filings/0001104659-26-010790.md) | [73.5](/filings/0001104659-26-088569.md) | [95.3](/filings/0001104659-26-088569.md) |
| Current assets | $m | [898](/filings/0001140361-23-051058.md) | [918](/filings/0001140361-24-004740.md) | [894](/filings/0001558370-25-008058.md) | [914](/filings/0001140361-24-035058.md) | [953](/filings/0001558370-24-013912.md) | [906](/filings/0001558370-25-000648.md) | [961](/filings/0001104659-26-066795.md) | [1,155](/filings/0001558370-25-009865.md) | [1,252](/filings/0001104659-25-103646.md) | [1,304](/filings/0001104659-26-010790.md) | [1,416](/filings/0001104659-26-088569.md) | [1,527](/filings/0001104659-26-088569.md) |
| Total assets | $m | [1,605](/filings/0001140361-23-051058.md) | [1,651](/filings/0001140361-24-004740.md) | [1,852](/filings/0001558370-25-008058.md) | [1,866](/filings/0001140361-24-035058.md) | [1,916](/filings/0001558370-24-013912.md) | [1,830](/filings/0001558370-25-000648.md) | [1,918](/filings/0001104659-26-066795.md) | [2,229](/filings/0001558370-25-009865.md) | [2,386](/filings/0001104659-25-103646.md) | [2,483](/filings/0001104659-26-010790.md) | [2,675](/filings/0001104659-26-088569.md) | [2,795](/filings/0001104659-26-088569.md) |
| Current liabilities | $m | [493](/filings/0001140361-23-051058.md) | [476](/filings/0001140361-24-004740.md) | [546](/filings/0001558370-25-008058.md) | [508](/filings/0001140361-24-035058.md) | [537](/filings/0001558370-24-013912.md) | [484](/filings/0001558370-25-000648.md) | [541](/filings/0001104659-26-066795.md) | [562](/filings/0001558370-25-009865.md) | [626](/filings/0001104659-25-103646.md) | [596](/filings/0001104659-26-010790.md) | [729](/filings/0001104659-26-088569.md) | [750](/filings/0001104659-26-088569.md) |
| Total liabilities | $m | [931](/filings/0001140361-23-051058.md) | [916](/filings/0001140361-24-004740.md) | [1,096](/filings/0001558370-25-008058.md) | [1,070](/filings/0001140361-24-035058.md) | [1,048](/filings/0001558370-24-013912.md) | [967](/filings/0001558370-25-000648.md) | [999](/filings/0001104659-26-066795.md) | [1,210](/filings/0001558370-25-009865.md) | [1,325](/filings/0001104659-25-103646.md) | [1,353](/filings/0001104659-26-010790.md) | [1,472](/filings/0001104659-26-088569.md) | [1,586](/filings/0001104659-26-088569.md) |
| Long-term debt | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Current portion of debt | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Short-term borrowings | $m | [0.1](/filings/0001140361-23-051058.md) | [0.0](/filings/0001140361-24-004740.md) | [12.0](/filings/0001558370-25-008058.md) | [4.3](/filings/0001140361-24-035058.md) | [14.0](/filings/0001558370-24-013912.md) | [2.4](/filings/0001558370-25-000648.md) | [9.3](/filings/0001104659-26-066795.md) | not reported | [12.4](/filings/0001104659-25-103646.md) | [1.2](/filings/0001104659-26-010790.md) | [7.5](/filings/0001104659-26-088569.md) | [8.1](/filings/0001104659-26-088569.md) |
| Shareholders' equity | $m | [667](/filings/0001140361-23-051058.md) | [727](/filings/0001140361-24-004740.md) | [748](/filings/0001558370-25-008058.md) | [788](/filings/0001140361-24-035058.md) | [859](/filings/0001558370-24-013912.md) | [855](/filings/0001558370-25-000648.md) | [910](/filings/0001104659-26-066795.md) | [1,012](/filings/0001558370-25-009865.md) | [1,054](/filings/0001104659-25-103646.md) | [1,122](/filings/0001104659-26-010790.md) | [1,195](/filings/0001104659-26-088569.md) | [1,202](/filings/0001104659-26-088569.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: not reported
- Current portion of debt: not reported
- Short-term borrowings: us-gaap:ShortTermBorrowings
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q2 FY2024 (2023-09-30) | Q3 FY2024 (2023-12-31) | Q4 FY2024 (2024-03-31) | Q1 FY2025 (2024-06-30) | Q2 FY2025 (2024-09-30) | Q3 FY2025 (2024-12-31) | Q4 FY2025 (2025-03-31) | Q1 FY2026 (2025-06-30) | Q2 FY2026 (2025-09-30) | Q3 FY2026 (2025-12-31) | Q4 FY2026 (2026-03-31) | Q1 FY2027 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [69.1 d](/filings/0001558370-24-013912.md) | [64.2 d](/filings/0001558370-25-000648.md) | [39.6 d](/filings/0001104659-26-066795.md) | [40.5](/filings/0001558370-25-009865.md) | [57.3 d](/filings/0001104659-25-103646.md) | [60.7 d](/filings/0001104659-26-010790.md) | [54.8 d](/filings/0001104659-26-066795.md) | [27.7](/filings/0001104659-26-088569.md) | [1.4 d](/filings/0001104659-25-103646.md) | [24.7 d](/filings/0001104659-26-010790.md) | [195 d](/filings/0001104659-26-066795.md) | [41.4](/filings/0001104659-26-088569.md) |
| Capital expenditure | $m | [11.1 d](/filings/0001558370-24-013912.md) | [17.6 d](/filings/0001558370-25-000648.md) | [43.9 d](/filings/0001104659-26-066795.md) | [26.8](/filings/0001558370-25-009865.md) | [13.5 d](/filings/0001104659-25-103646.md) | [16.0 d](/filings/0001104659-26-010790.md) | [27.7 d](/filings/0001104659-26-066795.md) | [27.5](/filings/0001104659-26-088569.md) | [31.9 d](/filings/0001104659-25-103646.md) | [41.8 d](/filings/0001104659-26-010790.md) | [42.1 d](/filings/0001104659-26-066795.md) | [46.4](/filings/0001104659-26-088569.md) |
| Share repurchases | $m | [9.1 d](/filings/0001558370-24-013912.md) | [7.3 d](/filings/0001558370-25-000648.md) | [0.1 d](/filings/0001104659-26-066795.md) | [4.7](/filings/0001558370-25-009865.md) | [3.1 d](/filings/0001104659-25-103646.md) | [4.5 d](/filings/0001104659-26-010790.md) | [18.6 d](/filings/0001104659-26-066795.md) | [5.1](/filings/0001104659-26-088569.md) | [0.6 d](/filings/0001104659-25-103646.md) | [1.1 d](/filings/0001104659-26-010790.md) | [0.2 d](/filings/0001104659-26-066795.md) | [64.6](/filings/0001104659-26-088569.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q2 FY2023 (2022-09-30) | Q3 FY2023 (2022-12-31) | Q1 FY2024 (2023-06-30) | Q2 FY2024 (2023-09-30) | Q3 FY2024 (2023-12-31) | Q1 FY2025 (2024-06-30) | Q2 FY2025 (2024-09-30) | Q3 FY2025 (2024-12-31) | Q1 FY2026 (2025-06-30) | Q2 FY2026 (2025-09-30) | Q3 FY2026 (2025-12-31) | Q1 FY2027 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [52.7](/filings/0001140361-23-051058.md) | [52.9](/filings/0001140361-24-004740.md) | [53.0](/filings/0001140361-24-035058.md) | [53.4](/filings/0001558370-24-013912.md) | [53.2](/filings/0001558370-25-000648.md) | [53.9](/filings/0001558370-25-009865.md) | [53.9](/filings/0001104659-25-103646.md) | [53.9](/filings/0001104659-26-010790.md) | [53.7](/filings/0001104659-26-088569.md) | [53.8](/filings/0001104659-25-103646.md) | [52.8](/filings/0001104659-26-010790.md) | [54.0](/filings/0001104659-26-088569.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 53,112,708 at 2026-07-24, from the cover of the [10-Q filed 2026-07-30](/filings/0001104659-26-088569.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:19 ET. No prices; not investment advice.